Disease, destination, dose and delivery aspects of ciclosporin: the state of the art
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 11 (17-18), 846-854
- https://doi.org/10.1016/j.drudis.2006.07.015
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- A water-soluble prodrug of cyclosporine A for ocular application: A stability studyEuropean Journal of Pharmaceutical Sciences, 2005
- Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liverInternational Immunopharmacology, 2005
- Effect of epigallocatechin gallate on renal function in cyclosporine-induced nephrotoxicityTransplantation Proceedings, 2004
- Cyclosporine nephrotoxicityTransplantation Proceedings, 2004
- Cyclosporin A prodrugs: design, synthesis and biophysical propertiesChemical Biology & Drug Design, 2004
- The history of cyclosporin A (Sandimmune®) revisited: Another point of viewCellular and Molecular Life Sciences, 1996
- Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulationsJournal of Medicinal Chemistry, 1993
- CyclosporinDrugs, 1993
- Progress towards a molecular understanding of cyclosporin A-mediated immunosuppressionThe Clinical Investigator, 1992
- Synthesis of cyclosporine. Total syntheses of ‘cyclosporin A’ and ‘cyclosporin H’, two fungal metabolites isolated from the species Tolypocladium inflatum GAMSHelvetica Chimica Acta, 1984